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As  reported  in  the  preceding  article,  administration  of sheep  anti-mouse 
interferon globulin to mice infected with encephalomyocarditis (EMC) 1 virus 
resulted in the multiplication  of virus to high titers in visceral organs,  rapid 
onset of disease, and early death. These results demonstrated the importance of 
the early production of mouse interferon in the response to this experimental 
virus  disease.  It  was considered of interest  to  extend these  studies to  other 
viruses exhibiting  different pathogeneses.  We describe  herein  the  results  of 
experiments undertaken  with herpes simplex virus  (HSV), Moloney sarcoma 
virus (MSV), vesicular stomatitis virus (VSV), Newcastle disease virus (NDV), 
and influenza virus type A. 
Materials and Methods 
Mice.  Unless otherwise stated,  1-mo-old male Swiss mice from a  pathogen-free colony at the 
Institut  du  Cancer  were  used  in  these  experiments.  For  one  experiment  BALB/c  mice  were 
obtained from a  mouse colony of the H6pital Cochin, Paris, France. 
Viruses.  The source of viruses used is described in Table I.  Techniques of intranasal  (i.n.) 
infection of mice with VSV or influenza virus have been previously described (4). 
Sheep Anti-Mouse Interferon  Globulin.  The techniques of preparation, semipurification, and 
assay of  sheep anti-mouse interferon  globulin (and normal sheep serum globulin)  were described 
in the preceding article.  In the experiments to be described both globulin preparations were 
diluted  1:3  in  phosphate-buffered saline.  Animals were inoculated with viruses and immediately 
injected  with 0.1 ml of  anti-interferon  globulin (or  0.14  ml normal sheep serum globulin)  intrave- 
nously (i.v.)  or as indicated. 
I. 
Results 
Effect of Sheep Anti-Interferon Globulin on Infection of Mice with HSV Type 
In a total of seven experiments, i.v. administration of anti-mouse interferon 
* Supported in  part  by  grants from  the  Ddldgation Ministdrielle  pour  l'Armement; Direction  des 
Recherches et  Moyens d'Essais,  contract  no. 75/141;  and  the  Foundation Simone et  Cino Del Duca. 
i  Abbreviations  used in this paper: EMC, encephalomyocarditis; HSV, herpes simplex virus; 
i.n.,  intranasal;  MSV, Moloney sarcoma virus;  NDV, Newcastle disease virus;  VSV, vesicular 
stomatitis  virus. 
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TABLE  I 
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Virus  Strain  Obtained from:  Passaged in 
HSV type I  F  (1)  Dr. P.  Sheldrick  Rabbit skin fibroblasts 
HSV type I  B-12 (2)  Dr. P.  Sheldrick  Rabbit skin fibroblasts 
MSV  -  (3)  Dr. J. P.  l_~vy  BALB/c mice 
VSV  Indiana  Our laboratory  Mouse L cells 
NDV  Herts  Our laboratory  Allantoic cavity 
Influenza A  PR 8  Dr. C. Hannoun  Embryonated egg 
globulin (titer, 4  ×  10  -5) resulted in the early appearance of disease and death, 
and increased the overall mortality due to HSV injected either intraperitoneally 
(i.p.) or subcutaneously (s.c.) (Figs. 1 and 2). Thus, when mice were inoculated 
i.p.  with the F  strain and then injected with normal serum globulin, the LD~o 
was 10-28/0.2 ml compared to an LDso of 10-5'6/0.2 rnl in mice treated with anti- 
interferon globulin (Fig. 1). Comparable results were obtained with strain B-12. 
This enhancing effect was even more striking when HSV was inoculated s.c. 
(Fig. 2). In three experiments only 1 mouse died of 19 mice treated with normal 
serum globulin and injected with a  10  -1 dilution of strain B-12 (none of 20 mice 
died after injection of a  10  -2  dilution of virus). In contrast, the LD~o/0.2 ml in 
mice treated with anti-interferon globulin in these three experiments was 10  -2.7 , 
10  -2"5, and 10  -LI, respectively. 
25 mice having survived HSV inoculation (s.c. or i.p.) were injected with anti- 
interferon  globulin  18  days  after  viral  inoculation.  In  no  instance  did  this 
treatment induce signs of HSV disease. 
Effect of Anti-Interferon Globulin on Infection of Mice with MSV.  6-wk-old 
BALB/c mice were injected intramuscularly (i.m.) with 0.1 ml of 10-fold dilu- 
tions of MSV  in the hind leg.  Administration of anti-interferon globulin in- 
creased the number of animals bearing tumors (at each dilution of virus tested) 
and shortened the latent period before appearance (Fig. 3 A). The tumor size was 
estimated by daily palpation for each mouse and scored on a scale of  0, 1/2, 1, etc., 
to a  maximum of 3.  There was a  striking difference between the mean tumor 
score of tumor-bearing mice treated with anti-interferon globulin and the two 
groups of control mice (Fig. 3 B).  Furthermore the overall tumor-inducing dose 
of 50/0.2  ml of MSV was  10  -3"1 for anti-interferon globulin-treated mice com- 
pared to 10  -L~ and 10  -°'s for the two groups of control mice.  Despite a  second 
injection of antiserum at 2 wk, regression of tumor occurred in all mice in all 
three groups and no deaths were observed. 
Effect of Anti-Interferon  Globulin on Infection of Mice with VSV.  In four 
experiments  1-mo-old  mice  were  inoculated i.n.  with  VSV  and the  globulin 
preparations  inoculated either i.v.  (0.1  ml)  or  intracerebrally (i.c.)  (0.03 ml) 
several hours later. Administration of anti-interferon globulin i.v. resulted in 
an acceleration by approximately 3 days in the onset of symptoms and death 
(Fig. 4 A), whereas a single injection of this globulin i.c. resulted in a difference 
of one day (Fig. 4 B).  Neither route of administration altered the LDso of VSV. 
VSV  injected i.p.  did  not  cause  any  apparent  disease  in  untreated or  anti- 
interferon globulin-treated mice. 
Effect  of Anti-Interferon  Globulin  on  Infection  of  Newborn  Mice  with Virus 
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FIG.  1.  1-mo-old Swiss mice were inoculated i.p.  with 10-fold dilutions of the F  strain of 
HSV type I, and treated (i.v.) with sheep anti-mouse interferon globulin (titer, 4  ×  10-'~), 
(O); or normal sheep globulin, (©). 
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FIG.  2.  1-mo-old Swiss mice were inoculated s.c.  with 10-fold dilutions of B-12 strain of 
HSV type I, and treated (i.v.) with sheep anti-mouse interferon globulin (titer, 4  ×  10-5), 
(0); or normal sheep globulin, (©). 
NDV.  NDV inoculated into newborn mice induces the production of interferon 
(titers of 1:320 to 1:960 per 10% homogenate of newborn mouse). In two experi- 
ments newborn mice were inoculated s.c.  with approximately 108 mean tissue 
culture infective doses  (TCIDso)  of NDV  and  then  injected s.c.  with  normal 
serum  globulin or anti-interferon globulin.  The mortality in the two  experi- 
ments in NDV-infected newborn mice treated with normal serum globulin was 
60%  (19/32  mice) and 66%  (20/30  mice) with a  median day of death of 9 days, 1320 
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Fro.  3.  6-wk-old  BALB/c  mice  were  injected  i.m.  with  10-fold  dilutions  of  MSV  and 
treated  (i.v.)  with sheep anti-mouse interferon  globuhn  (titer,  4  x  10-5),  (0);  or normal 
sheep globulin,  (©); or left untreated,  (X). 
whereas 100% (33/33 and 31/31 mice) of mice treated with anti-interferon globu- 
lin died with a  median day of death of 5 days.  Three mice in each group were 
sacrificed on the 5th day and the virus titers (TCIDso/0.2 ml of 10% homogenate 
of whole mouse as  assayed on chick monolayer fibroblasts)  were  10 -4.2,  10 -3.7, 
and  10 -37 for mice treated  with  normal  serum globulin;  and  10 -5-~, 10 -5-2, and 
10 -5.2 for mice treated with anti-~nterferon globulin. 
Effect  of Anti-Interferon  Globulin  on  Infection  of Mice  with  Influenza  A 
Virus.  Swiss mice were infected i.n.  with  0.1  ml of 10-fold dilutions  of virus 
and  approximately 4  h  later  were  injected  i.v.  with  0.1  ml  of anti-interferon 
globulin. The LDs0 of influenza virus was 10 -3.7 for untreated mice, 10 -4 for mice 
injected  with  normal  serum  globulin,  and  10 -4.2 for  mice  treated  with  anti- 
interferon globulin. 
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FIG.  4.  1-mo-old Swiss mice were inoculated i.n. with approximately 1,000 LDso of VSV. 
Mice were treated i.v.  (A) or i.c.  (B) with sheep anti-mouse interferon globulin (titer, 4  × 
10-~),  (0); normal sheep globulin, (O); or left untreated,  (X). 
several hours later the globulin preparations were also administered i.n. Again 
no significant difference was observed between the different groups. 
Discussion 
In the preceding paper we analyzed in some detail the effect of sheep anti- 
mouse interferon globulin on EMC virus infection in mice. In this article we 
have been  concerned with its effect on  HSV type I,  MSV,  VSV,  NDV,  and 
influenza virus infections in mice. 
Inoculation of mice with anti-interferon globulin was associated with a  very 
marked effect on the  evolution of HSV  disease,  as  shown by an accelerated 
appearance  of signs  of disease  and death.  Furthermore there  was a  several 
hundredfold increase in the overall LDso (both by i.p.  and s.c. routes). In fact, 
the B-12 strain of herpes simplex was only rarely lethal (5% mortality) when 
inoculated s.c., but proved highly lethal (100% mortality) in mice injected with 
anti-interferon globulin. The studies of Johnson (5, 6) indicate that the relative 
resistance of adult mice to extraneural inoculation of HSV is due to an age- 
related macrophage barrier.  Although macrophages from adult mice became 
infected in vitro, HSV did not spread to neighboring macrophages (6). Johnson 
found no  evidence to  indicate that  interferon was the  factor responsible  for 
limiting virus dissemination (6). Nevertheless, our studies with the use of anti- 
interferon serum suggest that the early interferon response is clearly important 
in the pathogenesis of herpes simplex in mice. 
There have been conflicting reports as to the efficacy of exogenous interferon 
in delaying the appearance of  tumors in weanling mice infected with MSV (7, 8). 
We are not aware of any reports demonstrating the presence of interferon in 
MSV-infected tissues and it has even been reported that infection of cells in vitro 
with MSV inhibits interferon action (9). However, our results suggest that MSV 
probably induces the synthesis of interferon initially since in anti-interferon 
globulin-treated mice, tumors appeared earlier,  were much larger,  and were 1322  INTERFERON  IN  VIRUS  INFECTIONS  OF  MICE.  II 
present longer than in the two groups of control mice.  In addition the overall 
tumor-inducing  dose,  50,  of the virus preparation  was  100-fold greater in the 
anti-interferon  globulin-treated mice.  However in this system, interferon does 
not play a  role in tumor regression since tumors regressed in all mice despite 
reinjection of anti-interferon  globulin. 
When VSV is inoculated i.n. it is thought to reach the brain via the olfactory 
nerves  (10).  Administration  of anti-interferon  globulin  clearly  decreased the 
latent period before onset of symptoms and death, although the site of produc- 
tion of interferon is unknown, i.e. whether it occurs in nasal mucosa, olfactory 
nerves, or the central nervous system. Anti-interferon globulin did not influence 
the course of disease in influenza virus-infected mice (even when the globulin 
was injected i.n.).  Perhaps the absence of effect in influenza  infection may be 
related to the inability of the globulin to diffuse to the tracheobronchial epithe- 
lium,  and  does  not  necessarily  imply  that  interferon  is  unimportant  in  the 
pathogenesis of influenza virus infection. 
The interferon response was also demonstrated to be of importance  in new- 
born mice as exemplified by the rapid onset of disease and increased mortality in 
NDV-infected mice treated with anti-interferon  globulin. 
In conclusion, the use of sheep anti-mouse interferon serum in several differ- 
ent  experimental  virus  diseases  of mice  exhibiting  totally  dissimilar  patho- 
geneses,  [i.e.  an  acute  systemic  viral  disease  exemplified  by  HSV,  a  local 
oncogenic virus disease (MSV), and an acute viral encephalitis (VSV)] indicates 
the  general  importance  of the  early interferon  response in host resistance  to 
virus infection. 
Summary 
The effect of potent sheep anti-mouse interferon globulin was investigated in 
several different experimental virus diseases of mice. In anti-interferon  globu- 
lin-treated  mice  infected  intraperitoneally  with  herpes  simplex  virus  (HSV) 
type I,  the  latent  period was  shortened,  and  the  overall  LD5o was increased 
several hundredfold compared to virus-infected control mice.  When HSV was 
inoculated  subcutaneously  all  anti-interferon  globulin-treated  mice  died, 
whereas only 5% of virus-infected control mice died. Subsequent treatment with 
anti-interferon globulin of previously HSV-infected mice did not result in reacti- 
vation of HSV. Treatment of adult mice with anti-interferon globulin resulted in 
an earlier appearance of MSV-induced tumors, a  greater number of mice bear- 
ing tumors, an increase in tumor size, and an increase in the duration of tumors. 
All tumors eventually regressed despite reinjection of anti-interferon  globulin. 
Anti-interferon globulin treatment resulted in a rapid onset of disease and death 
in adult mice inoculated  (intranasal)  with VSV and in newborn mice infected 
with NDV. Anti-interferon globulin exerted no effect on the course of influenza 
virus infection of mice. We conclude that the early production of interferon is an 
important  element in the response of the mouse to several viruses exhibiting 
different pathogeneses. 
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